Literature DB >> 26683212

In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.

Yaofeng Cheng1, Thomas F Woolf2, Jinping Gan1, Kan He3.   

Abstract

The bile salt export pump protein (BSEP), expressed on the canalicular membranes of hepatocytes, is primarily responsible for the biliary excretion of bile salts. The inhibition of BSEP transport activity can lead to an increase in intracellular bile salt levels and liver injury. This review discusses the various in vitro assays currently available for assessing the effect of drugs or other chemical entities to modulate BSEP transport activity. BSEP transporter assays use one of the following platforms: Xenopus laevis oocytes; canalicular membrane vesicles (CMV); BSEP-expressed membrane vesicles; cell lines expressing BSEP; sandwich cultured hepatocytes (SCH); and hepatocytes in suspension. Two of these, BSEP-expressed insect membrane vesicles and sandwich cultured hepatocytes, are the most commonly used assays. BSEP membrane vesicles prepared from transfected insect cells are useful for assessing BSEP inhibition or substrate specificity and exploring mechanisms of BSEP-associated genetic diseases. This model can be applied in a high-throughput format for discovery-drug screening. However, experimental results from use of membrane vesicles may lack physiological relevance and the model does not allow for investigation of in situ metabolism in modulation of BSEP activity. Hepatocyte-based assays that use the SCH format provide results that are generally more physiologically relevant than membrane assays. The SCH model is useful in detailed studies of the biliary excretion of drugs and BSEP inhibition, but due to the complexity of SCH preparation, this model is used primarily for determining biliary clearance and BSEP inhibition in a limited number of compounds. The newly developed hepatocyte in suspension assay avoids many of the complexities of the SCH method. The use of pooled cryopreserved hepatocytes in suspension minimizes genetic variance and individual differences in BSEP activity and also provides the opportunity for higher throughput screening and cross-species comparisons.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bile salt export pump (BSEP); Cholestasis; Hepatocytes; In vitro assay; Liver injury; Membrane vesicle

Mesh:

Substances:

Year:  2015        PMID: 26683212     DOI: 10.1016/j.cbi.2015.11.029

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  7 in total

Review 1.  A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis.

Authors:  Brandy Garzel; Lei Zhang; Shiew-Mei Huang; Hongbing Wang
Journal:  Curr Drug Metab       Date:  2019       Impact factor: 3.731

Review 2.  Bile Acids Transporters of Enterohepatic Circulation for Targeted Drug Delivery.

Authors:  Robin Durník; Lenka Šindlerová; Pavel Babica; Ondřej Jurček
Journal:  Molecules       Date:  2022-05-05       Impact factor: 4.927

3.  Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.

Authors:  Jie Zhang; Kan He; Lining Cai; Yu-Chuan Chen; Yifan Yang; Qin Shi; Thomas F Woolf; Weigong Ge; Lei Guo; Jürgen Borlak; Weida Tong
Journal:  Chem Biol Interact       Date:  2016-03-19       Impact factor: 5.192

4.  Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile.

Authors:  Xiao-Li Xiong; Yan Ding; Zhi-Lin Chen; Yao Wang; Pan Liu; Huan Qin; Li-Shan Zhou; Ling-Ling Zhang; Juan Huang; Lei Zhao
Journal:  Front Pharmacol       Date:  2019-05-22       Impact factor: 5.810

Review 5.  The Bile Salt Export Pump: Molecular Structure, Study Models and Small-Molecule Drugs for the Treatment of Inherited BSEP Deficiencies.

Authors:  Muhammad Imran Sohail; Yaprak Dönmez-Cakil; Dániel Szöllősi; Thomas Stockner; Peter Chiba
Journal:  Int J Mol Sci       Date:  2021-01-14       Impact factor: 5.923

6.  Mouse precision-cut liver slices as an ex vivo model to study drug-induced cholestasis.

Authors:  R E H Karsten; N J W Krijnen; W Maho; H Permentier; E Verpoorte; P Olinga
Journal:  Arch Toxicol       Date:  2022-06-16       Impact factor: 6.168

7.  Kuhuang injection exerts a protective effect by activating PPAR-γ in an in vitro model of chlorpromazine-induced cholestatic liver injury constructed by tissue engineering.

Authors:  Qiao Wu; Zhongping Duan; Long Huang; Zhijie Li
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.